BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · IEX Real-Time Price · USD
1.190
-0.050 (-4.03%)
Jul 19, 2024, 10:12 AM EDT - Market open

BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $44.29 million. The enterprise value is $74.38 million.

Market Cap 44.29M
Enterprise Value 74.38M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date Aug 12, 2024
Ex-Dividend Date n/a

Share Statistics

BTAI has 37.53 million shares outstanding. The number of shares has increased by 7.87% in one year.

Shares Outstanding 37.53M
Shares Change (YoY) +7.87%
Shares Change (QoQ) +4.86%
Owned by Insiders (%) 21.78%
Owned by Institutions (%) 34.27%
Float 25.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 26.50
Forward PS 10.50
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 42.36
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.57

Current Ratio 2.57
Quick Ratio 2.37
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -10.29

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -154.40%
Return on Capital (ROIC) -488.69%
Revenue Per Employee $23,730
Profits Per Employee -$2.07M
Employee Count 74
Asset Turnover 0.02
Inventory Turnover 0.61

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -89.02% in the last 52 weeks. The beta is 0.32, so BTAI's price volatility has been lower than the market average.

Beta (5Y) 0.32
52-Week Price Change -89.02%
50-Day Moving Average 1.55
200-Day Moving Average 2.74
Relative Strength Index (RSI) 44.37
Average Volume (20 Days) 856,801

Short Selling Information

The latest short interest is 1.62 million, so 4.32% of the outstanding shares have been sold short.

Short Interest 1.62M
Short Previous Month 1.49M
Short % of Shares Out 4.32%
Short % of Float 6.27%
Short Ratio (days to cover) 2.11

Income Statement

In the last 12 months, BTAI had revenue of $1.76 million and -$153.05 million in losses. Loss per share was -$5.17.

Revenue 1.76M
Gross Profit 424,000
Operating Income -144.75M
Pretax Income -153.05M
Net Income -153.05M
EBITDA -139.18M
EBIT -139.50M
Loss Per Share -$5.17
Full Income Statement

Balance Sheet

The company has $74.14 million in cash and $101.98 million in debt, giving a net cash position of -$27.84 million or -$0.74 per share.

Cash & Cash Equivalents 74.14M
Total Debt 101.98M
Net Cash -27.84M
Net Cash Per Share -$0.74
Equity (Book Value) -72.36M
Book Value Per Share -1.93
Working Capital 49.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$120.36 million and capital expenditures -$20,000, giving a free cash flow of -$120.38 million.

Operating Cash Flow -120.36M
Capital Expenditures -20,000
Free Cash Flow -120.38M
FCF Per Share -$3.90
Full Cash Flow Statement

Margins

Gross margin is 24.15%, with operating and profit margins of -8,243.11% and -8,715.72%.

Gross Margin 24.15%
Operating Margin -8,243.11%
Pretax Margin -8,715.72%
Profit Margin -8,715.72%
EBITDA Margin -7,925.91%
EBIT Margin -7,943.91%
FCF Margin -6,855.30%

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.87%
Shareholder Yield -7.87%
Earnings Yield -328.87%
FCF Yield -258.67%

Analyst Forecast

The average price target for BTAI is $6.00, which is 404.20% higher than the current price. The consensus rating is "Buy".

Price Target $6.00
Price Target Difference 404.20%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 139.31%
EPS Growth Forecast (5Y) -48.90%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BTAI has an Altman Z-Score of -15.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.17
Piotroski F-Score 2